Acridinium esters as high-specific-activity labels in immunoassay

Area of Science:

• Biochemistry
• Immunology
• Analytical Chemistry

Background:

• Development of sensitive detection methods for biomarkers like human alpha 1-fetoprotein (AFP) is crucial for early disease diagnosis.
• Chemiluminescent labels offer high sensitivity and low background noise in immunoassays.

Purpose of the Study:

• To synthesize a novel chemiluminescent acridinium ester for protein labeling.
• To develop highly active, stable chemiluminescent protein conjugates.
• To establish a sensitive immunochemiluminometric assay for human AFP.

Main Methods:

• Synthesis of a chemiluminescent acridinium ester.
• Conjugation of the ester to monoclonal antibodies against human AFP.
• Characterization of the chemiluminescent antibodies' specific activity and incorporation ratio.
• Development and preliminary testing of a two-site immunochemiluminometric assay for AFP.

Main Results:

• A stable, chemiluminescent acridinium ester derivative of proteins was successfully synthesized.
• Chemiluminescent monoclonal antibodies to human AFP were prepared with high specific activity (up to 2.8 mol label/mol antibody).
• A detection limit of approximately 8 x 10(-19) mol was achieved.
• A rapid (30-min incubation, 5-s quantification) two-site immunochemiluminometric assay for AFP was preliminarily developed.

Conclusions:

• The novel chemiluminescent acridinium ester provides a versatile tool for creating highly sensitive protein-based detection systems.
• The developed chemiluminescent antibodies and assay show significant potential for rapid and sensitive human AFP quantification.
• This approach may be applicable to other protein biomarker detection assays.